The new public offering, in which Zymeworks sold a combination of stock and warrants amounting to 12.5 million shares, represented a 27% dilution of its share count, the Globe and Mail reported。
太惨了。100M稀释27%。
我不希望是康方
big fks small
主要股东是礼来,估计也是准备卖给礼来
折价稀释股权…老股东亏大了。这还得要有人愿意买。